Metronidazole Pediatric Dose Calculator

Metronidazole is secreted in saliva and creates a characteristic metallic or bitter taste in the mouth. This side effect is one of the most common complaints and can reduce medication compliance in children. Strategies to manage this include mixing the compounded suspension with chocolate syrup, following doses with strong-flavored drinks or candy, and using a syringe to place the medication at the back of the throat.

Metronidazole inhibits the enzyme aldehyde dehydrogenase, which is needed to metabolize alcohol. Combining the two can cause a disulfiram-like reaction with symptoms including severe nausea, vomiting, flushing, headache, and abdominal cramps. While this is primarily a concern for adolescents and adults, parents should be aware that some liquid medications and mouthwashes contain alcohol and should be avoided during treatment.

Metronidazole is extremely bitter and difficult to formulate into a palatable liquid. No pharmaceutical manufacturer has successfully developed a commercially viable pediatric liquid formulation for the US market. Compounding pharmacies prepare custom suspensions by crushing tablets and suspending them in sweetened vehicles with flavoring agents. These compounded formulations require refrigeration and typically expire within 14 days.

Metronidazole can be used in infants under physician supervision, though dosing adjustments may be needed for neonates due to immature hepatic metabolism. The drug has a longer half-life in newborns (25-75 hours vs 6-8 hours in older children). For neonates, especially premature infants, individualized dosing should be determined by a neonatologist or pediatric infectious disease specialist.

Prolonged use of metronidazole can cause peripheral neuropathy (tingling, numbness in extremities) and rarely central nervous system effects including seizures and cerebellar dysfunction. These effects are typically reversible upon discontinuation but can be permanent in rare cases. Neurological monitoring is important for courses exceeding 10 days, and the drug should be discontinued if neurological symptoms develop.

For initial non-severe C. difficile infection in children, the standard course is 10 days of oral metronidazole. For severe cases or first recurrence, oral vancomycin is preferred over metronidazole per current IDSA/SHEA guidelines. If C. difficile recurs after metronidazole treatment, the child should be switched to oral vancomycin rather than repeating the metronidazole course.

Metronidazole can be taken with or without food. Taking it with food may help reduce the nausea and metallic taste that are common side effects. For the compounded suspension, giving it with a small amount of food or immediately followed by a sweet drink can improve tolerability. The drug's absorption is not significantly affected by food intake, so consistency in administration is more important than timing relative to meals.